secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2026-06-17T20:15:20+00:00
Accession:  0001493152-26-029085
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Hepion shareholders approve 40x increase in equity plan shares to 8M at annual meeting
--------------------------------------------------------------------------------

- Elected directors Stetz, V. LoPriore, Purcell, Appajosyula, C. LoPriore with ~13.5M votes each.
- Ratified Grassi & Co. as auditors for FY2026: 18.1M for, 117K against, 223K abstain.
- Approved amendment to 2023 equity plan, increasing shares from 200K to 8M: 13.4M for, 209K against.
- Broker non-votes totaled 4.8M on director election and equity plan proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000149315226029085/0001493152-26-029085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000149315226029085/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-029085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer